Literature DB >> 7444833

Role of venography in assessing patients with superior caval obstruction caused by bronchial carcinoma for bypass operations.

J F Dyet, K Moghissi.   

Abstract

The value of venography in assessing the level of obstruction in mediastinal block and hence the selection of patients for bypass grafting is demonstrated, and an illustrative case is presented.

Entities:  

Mesh：

Year:  1980        PMID： 7444833      PMCID： PMC471348          DOI： 10.1136/thx.35.8.628

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  4 in total

1.  The superior vena cava obstruction syndrome in bronchogenic carcinoma; pathologic physiology and therapeutic management.

Authors:  B ROSWIT; G KAPLAN; H G JACOBSON
Journal:  Radiology       Date:  1953-11       Impact factor: 11.105

2.  Collateral pathways in occlusion of the superior vena cava and its tributaries.

Authors:  N H Okay; D Bryk
Journal:  Radiology       Date:  1969-06       Impact factor: 11.105

3.  Malignant obstruction of the superior vena cava and its palliation: report of four cases.

Authors:  R B Avasthi; K Moghissi
Journal:  J Thorac Cardiovasc Surg       Date:  1977-08       Impact factor: 5.209

4.  Combined superior vena cavography and azygography in patients with suspected lung carcinoma.

Authors:  C T Rinker; A W Templeton; J MacKenzie; G R Ridings; C H Almond; R Kiphart
Journal:  Radiology       Date:  1967-03       Impact factor: 11.105
  4 in total
  3 in total

Review 1.  Stenting of superior vena caval obstruction.

Authors:  J E Jackson; D M Brooks
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

2.  Computed tomographic evaluation of compression of the superior vena cava and its tributaries.

Authors:  W F Tatu; G G Winzelberg; M Boller; M H Wholey
Journal:  Cardiovasc Intervent Radiol       Date:  1985       Impact factor: 2.740

3.  Need for invasive diagnostic procedures in the management of superior vena cava syndrome.

Authors:  P P Kumar; R R Good
Journal:  J Natl Med Assoc       Date:  1989-01       Impact factor: 1.798
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.